Add BrightSurf on Google Email

University of Minnesota Medical School


University of Minnesota Medical School finds promising treatment to slow kidney disease doesn't prove out in clinical trial

A new clinical trial from the University of Minnesota Medical School found that allopurinol did not slow kidney function in people with type 1 diabetes, despite reducing uric acid levels. The three-year study enrolled 530 participants and followed their glomerular filtration rate to assess kidney health.

SourceUniversity of Minnesota Medical School·JournalNew England Journal of Medicine·DateJun 25, 2020

New research finds signal of decreased early post transplant survival in new heart transplant system

Researchers have identified a decrease in heart transplant survival rates following the implementation of a new donor allocation system in the US. The study found that patients receiving hearts are sicker than in previous systems, leading to an increase in post-transplant mortality.

SourceUniversity of Minnesota Medical School·JournalThe Journal of Heart and Lung Transplantation·DateNov 21, 2019

Researchers discover how three-dimensional organization of the genome regulates cell differentiation

Researchers from the University of Minnesota Medical School discovered that large loops form between DNA sequences where a key protein Pax3 binds, and these loops are essential for the development of skeletal muscle. The study shows how 3D genome organization regulates cell differentiation in skeletal muscle formation.

SourceUniversity of Minnesota Medical School·JournalNature Communications·DateMay 24, 2019

UMN researchers study effect of chronic opioid therapy on pain and survival in sickle cell disease

Researchers found that chronic morphine treatment decreased survival in control mice, but not in sickle mice with sickle cell disease. Chronic opioid therapy also caused hyperalgesia, a condition of increased pain sensitivity, in sickle mice. The study suggests that opioids may still be effective for managing pain in SCD patients despi...

SourceUniversity of Minnesota Medical School·JournalBlood Advances·DateApr 2, 2019

UMN study provides new insight into use of cell replacement therapies to treat muscular dystrophies

A University of Minnesota Medical School research breakthrough highlights the potential of cell therapies for treating muscular dystrophy. The study identifies the molecular signature of muscle stem cells generated in vitro and their transformation upon transplantation into mice with muscular dystrophy.

SourceUniversity of Minnesota Medical School·JournalProceedings of the National Academy of Sciences·DateFeb 13, 2019

Medical experts restore movement and autonomic function in patients with complete paralysis

Researchers at the University of Minnesota Medical School demonstrate spinal cord stimulation can immediately restore some voluntary movement and autonomic functions years after a paralyzing injury. The study expands inclusion guidelines for epidural stimulation, offering new hope for patients with traumatic spinal cord injury.

SourceUniversity of Minnesota Medical School·JournalJournal of Neurotrauma·DateJan 31, 2019

UMN medical school researchers study abnormal blood glucose levels of discharged patients

A study by University of Minnesota Medical School researchers found that patients with abnormal blood glucose ranges have a higher rate of hospital readmission and death in the 30 days after discharge. Patients with 'borderline' high glucose levels who are not diagnosed with diabetes also experience worse outcomes.

SourceUniversity of Minnesota Medical School·JournalJournal of General Internal Medicine·DateDec 14, 2018

UMN researchers discover important connection between cells in the liver

Researchers at the University of Minnesota Medical School have made a groundbreaking discovery about how liver cell communication affects disease progression. By studying the dialogue between hepatocytes and macrophages, they found that a specific ketone body metabolite helps protect against tissue fibrosis in non-alcoholic fatty liver...

SourceUniversity of Minnesota Medical School·JournalCell Metabolism·DateNov 15, 2018

UMN researchers use 3D technology to identify optimal stem cells for transplantation

Researchers at the University of Minnesota Medical School have discovered a subset of muscle stem cells that are located close to blood vessels and are likely to be the more potent stem cell population in maintaining muscle health. This groundbreaking study uses 3D technology to study the interaction between stem cells and blood vessel...

SourceUniversity of Minnesota Medical School·JournalCell Stem Cell·DateOct 4, 2018

UMN researchers discover influenza virus doesn't replicate equally in all cells

Researchers at the University of Minnesota Medical School have made a groundbreaking discovery about the influenza virus, finding that its replication rate differs significantly between various cell types. The study reveals that certain cells are protected from severe infection, while others remain vulnerable to viral damage.

SourceUniversity of Minnesota Medical School·JournalProceedings of the National Academy of Sciences·DateSep 19, 2018

Sticking with the wrong choice

Researchers discovered that mice, rats, and humans all exhibit the sunk cost fallacy, preferring to continue with a choice despite clear evidence of a better alternative. The study used economic games to test species' willingness to wait for rewards, finding that all three groups became more reluctant to quit as time passed.

UMN researchers develop algorithm to improve care delivery to seriously ill patients

Researchers at the University of Minnesota Medical School have developed an algorithm to better identify seriously ill hospitalized patients, empowering them to make informed decisions about their medical care. The data-driven approach aims to reduce unnecessary invasive procedures and improve end-of-life planning.

SourceUniversity of Minnesota Medical School·JournalJournal of General Internal Medicine·DateJul 6, 2018